CLDX - Celldex Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CLDX is currently covered by 8 analysts with an average price target of $74.7. This is a potential upside of $48.7 (187.31%) from yesterday's end of day stock price of $26.

Celldex Therapeutics's activity chart (see below) currently has 101 price targets and 101 ratings on display. The stock rating distribution of CLDX is 90% BUY and 10% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.47% with an average time for these price targets to be met of 88.69 days.

Highest price target for CLDX is $67, Lowest price target is $31, average price target is $47.38.

Most recent stock forecast was given by MARA GOLDSTEIN from MIZUHO on 20-Oct-2025. First documented stock forecast 18-Jun-2013.

Currently out of the existing stock ratings of CLDX, 18 are a BUY (90%), 2 are a HOLD (10%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$48

$21.28 (79.64%)

$3

10 days ago
(20-Oct-2025)

1/5 (20%)

$20.09 (71.98%)

248

Buy

$62

$35.28 (132.04%)

$62

1 months 14 days ago
(16-Sep-2025)

0/3 (0%)

$37.54 (153.48%)

Buy

$42

$15.28 (57.19%)

$50

2 months 11 days ago
(19-Aug-2025)

6/30 (20%)

$21.11 (101.05%)

256

Buy

$38

$11.28 (42.22%)

$37

2 months 11 days ago
(19-Aug-2025)

4/5 (80%)

$17.11 (81.91%)

165

Buy

$48

$21.28 (79.64%)

$70

2 months 11 days ago
(19-Aug-2025)

0/2 (0%)

$27.11 (129.78%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CLDX (Celldex Therapeutics) average time for price targets to be met?

On average it took 88.69 days on average for the stock forecasts to be realized with a an average price target met ratio 23.47

Which analyst has the current highest performing score on CLDX (Celldex Therapeutics) with a proven track record?

BIREN AMIN

Which analyst has the most public recommendations on CLDX (Celldex Therapeutics)?

Biren Amin works at PIPER SANDLER and has 5 price targets and 8 ratings on CLDX

Which analyst is the currently most bullish on CLDX (Celldex Therapeutics)?

Jonathan Aschoff with highest potential upside - $438.28

Which analyst is the currently most reserved on CLDX (Celldex Therapeutics)?

Boris Peaker with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?